Labshake search
Citations for R&D Systems :
1 - 50 of 1743 citations for Alpha Actinin 4 Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2024Quote: ... Recombinant Human Interferon alpha 2a (IFN-alpha) was purchased from R&D systems. Cisplatin was purchased from Sigma-Aldrich.
-
bioRxiv - Bioengineering 2024Quote: ... IDUA activity was assessed using 4-methylumberlliferyl-alpha-L-iduronide (Glycosynth, Cheshire, England) and recombinant human alpha-L-iduronidase protein (R&D systems, Minneapolis) following manufacturer’s instructions.
-
bioRxiv - Bioengineering 2022Quote: ... were coated with 4 μg ml-1 recombinant mouse IL-10 receptor alpha (R&D Systems) overnight at 4°C ...
-
bioRxiv - Molecular Biology 2019Quote: ... Recombinant Human TNF-alpha Protein purchased from R&D Systems was diluted in 1X Dulbecco’s phosphate buffered saline (DPBS ...
-
bioRxiv - Physiology 2020Quote: Recombinant human Mfge8 and recombinant human laminin subunit alpha-1 were purchased from R&D Systems, www.rndsystems.com ...
-
bioRxiv - Immunology 2022Quote: Recombinant Mouse IL-15R alpha Fc Chimera Protein (R&D Systems) and recombinant Mouse IL-15 (Tonbo Biosciences ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant Mouse Interferon Alpha-A (IFNα, R&D Systems, Inc. Minneapolis, MN) was administered either intratumorally or intramuscularly ...
-
Microbial signals and lymphotoxin drive TNF-independent death of A20 and ABIN-1 deficient epitheliumbioRxiv - Immunology 2021Quote: ... a recombinant mouse lymphotoxin alpha ELISA reference (a gift from R&D systems), peroxidase streptavidin (Jackson ImmunoResearch) ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human interleukin 4 (IL-4) (R&D Systems), Alpha MEM with nucleosides (StemCell Technologies ...
-
bioRxiv - Immunology 2020Quote: ... recombinant IL-4 (R&D systems), and anti-CD40 (ThermoFisher ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 10 mU recombinant DPP-4 (R&D Systems), or no enzyme as a control for non-enzymatic degradation over the same time period ...
-
bioRxiv - Pathology 2021Quote: A total of 50 μL/well of recombinant human IL5-Receptor alpha (R&D Systems, Minneapolis, MN) final concentration of (4 μg/mL ...
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
bioRxiv - Immunology 2021Quote: Recombinant CSF-1 (4 µg/dose; R&D Systems) was given to EAE mice on days 4 ...
-
bioRxiv - Biophysics 2020Quote: Recombinant human ADAMTS-4 (R&D Systems, Minneapolis, MN, USA) and MMP-13 (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... 5 ng/ml recombinant murine IL-4 (R&D Systems), and 5 ng/ml recombinant human TGF-β (R&D Systems) ...
-
bioRxiv - Cell Biology 2019Quote: ... recombinant syndecan-4 (R&D Systems Cat# 6267-SD-050) and recombinant syndecan-2 (R&D Systems Cat#6585-SD-050) ...
-
bioRxiv - Cancer Biology 2021Quote: Recombinant 52-kDa pro-cath-D (4 µM; R&D Systems) was auto-activated to 51-kDa pseudo-cath-D in 0.1 M Na-acetate buffer (pH 3.5) ...
-
bioRxiv - Developmental Biology 2019Quote: ... 4 ng human recombinant IGF2 (292-G2-050, R&D Systems) was used as positive control ...
-
bioRxiv - Bioengineering 2023Quote: ... and 20 ng/mL human recombinant FGF-4 (R&D Systems). After 9 to 13 days ...
-
bioRxiv - Cell Biology 2024Quote: ... 20 ng/ml recombinant mouse interleukin-4 (IL-4) (R&D Systems, Cat number: 404-ML) was used (25) ...
-
bioRxiv - Neuroscience 2022Quote: ... 506-RL-010/CF) and carrier free Recombinant Mouse TNF-alpha (aa 80-235) Protein (410-MT-025/CF) purchased from R&D Systems.
-
bioRxiv - Cancer Biology 2023Quote: ... Th2 condition: Recombinant human IL-4 (10 ng/ml, R&D Systems), IL-5 (10 ng/ml ...
-
bioRxiv - Genomics 2023Quote: ... followed by recombinant human BMP-4 (5 ng/mL; R&D Systems) and CHIR 99021 (1 nM ...
-
bioRxiv - Cell Biology 2024Quote: ... and 0.25 ng/mL recombinant human BMP-4 Protein (R&D Systems).Cells were cultured for 28 hours ...
-
bioRxiv - Biochemistry 2022Quote: ... anti-ERAP2 (mAb clone 3F5, MAB 3830 R&D Systems) (25) ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with recombinant human IL-4 (50 ng/mL) and recombinant human GM-CSF (100 ng/mL) (R&D Systems, Minneapolis, MN) with one additional supplement of fresh media and cytokines at day 3 of culture as previously described 12 ...
-
bioRxiv - Neuroscience 2022Quote: ... 25 µg/ml human recombinant Bone Morphogenetic Protein 4 (BMP4, R&D Systems) and 55 µM β-mercaptoethanol (Life technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Immunology 2021Quote: ... recombinant human IL-4 at 50 ng/ml (R&D Systems, Minneapolis, MN, USA) for 6 h ...
-
bioRxiv - Neuroscience 2022Quote: Pentraxins Binding C1q Purified recombinant neuronal pentraxin proteins (4 µg/mL, R&D Systems) or IgM (2 µg/mL ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 ng mL− 1 BMP-4 (human recombinant) (R&D Systems, Minneapolis, MN, USA), 10 µM LY294002 (Cayman Chemical ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-4 (R&D systems, #204-IL/CF). Inhibitors used were the PI3Kdelta inhibitor Idelalisib ...
-
bioRxiv - Immunology 2021Quote: ... 115-006-068), 250ng/ml mouse recombinant MEGACD40L (Enzo, ALX-522-120) and 20ng/ml Recombinant mouse IL-4 (R&D system, 404-ML). Cells were collected at specific time points for analysis ...
-
bioRxiv - Immunology 2021Quote: ... 109-006-127), 250ng/ml human recombinant MEGACD40L (Enzo, ALX-522-110) and 20ng/ml Recombinant human IL-4 (R&D system, 204-IL-010). Cells were collected at specific time points for analysis.
-
bioRxiv - Biochemistry 2024Quote: ... Gi-bound complex sample) or mixed with 0.5 mg/mL CXCL12 (Recombinant Human/Rhesus Macaque/Feline CXCL12/SDF-1 alpha, R&D Systems Catalog #: 350-NS-050/CF), or 1 mM AMD3100 (AMD 3100 octahydrochloride ...
-
bioRxiv - Molecular Biology 2022Quote: Human recombinant BMP-2 and BMP-4 were purchase from R&D Systems (Minneapolis, MN). Anti-Myc and anti-HA antibodies were purchased from Cell Signaling Technology (Danvers ...
-
bioRxiv - Immunology 2023Quote: ... and 25ng/ml recombinant mouse IL-4 (clone 404-ML-025/CF; R&D System) in final volume of 200 μl of RPMI 1640 medium supplemented with 10% FBS ...
-
bioRxiv - Immunology 2020Quote: ... 1.25% of supernatant from Con-A-stimulated rat splenocytes (assay positive control), c) recombinant canine IL-4 (rcaIL-4, 360 ng/mL) (R&D Systems), d ...
-
bioRxiv - Immunology 2021Quote: ... were coated with recombinant human CTLA-4-Fc (7268-CT, R&D Systems, Minneapolis, MN, USA) at 1 μg/mL overnight at 4°C ...
-
bioRxiv - Physiology 2024Quote: ... then stimulated with recombinant human IL-4 at 50 ng/mL (R&D Systems, Minneapolis, MN) in BEBM medium for 6 h or BEBM medium as control condition ...
-
bioRxiv - Cell Biology 2021Quote: ... mouse TNF-alpha (R&D Systems, MTA00B), mouse IL-6 (R&D Systems ...
-
bioRxiv - Cancer Biology 2024Quote: ... recombinant human IL-4 500 IU/mL and GM- CSF 800 IU/mL (both R&D systems) at a cell density of 1-2 x106 cells/mL for 5 days ...
-
bioRxiv - Microbiology 2022Quote: ... and TNF-alpha (Bio-Techne, R&D systems).
-
bioRxiv - Neuroscience 2023Quote: ... TNF-alpha (catalog no.DY410-05, R&D System), and IL1-beta (catalog no.DY401-05 ...
-
bioRxiv - Neuroscience 2022Quote: ... were immobilized and were treated with His-tagged recombinant neuronal pentraxin proteins (4 µg/mL, R&D Systems). The readout was HRP-conjugated anti-His tag antibody recognizing the pentraxin proteins (abcam).
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed every day to HDM with 20 ng/mL human recombinant BMP-4 (R&D Systems) and 20 ng/mL human recombinant FGF-4 (R&D Systems) ...
-
bioRxiv - Molecular Biology 2022Quote: ... anti-HBP (mAb #246322, R&D systems), anti-HBP (pAb ab167336 ...
-
bioRxiv - Microbiology 2020Quote: ... Recombinant human galectin-4 (GAL4 P56470) and gelsolin (GSN Q3SX14) from bovine plasma were purchased from R&D Systems and Sigma respectively.